Synopsys, Inc. (Nasdaq:SNPS)
April 23rd, 2019
Amidst rising markets Synopsys, Inc. closed Tuesday up 2.48%, a $2.90 increase to close on $119.89. Furthermore it hit a new 52 week high of $120.75. The next earnings report is expected in approximately 28 days.
SNPS outperformed the rest of the Information Technology sector which went up 1.13% today.
Synopsys, Inc. is listed on the S&P 500 index, and was one of 397 stocks that rose today. Weighted by market cap, SNPS represents about 0.07% of the S&P 500.
Forecasts from 8 analysts suggest that Synopsys, Inc. might increase somewhat (5.77%), while Finbox has calculated (with low uncertainty) a fair value price of $97.02.
The market sectors were mixed Tuesday with a majority of the sectors trending up. Healthcare saw the biggest increase of the day (1.59%), while Consumer Staples saw the biggest drop (-0.12%). Information Technology has seen the biggest year-to-date gain at 25.74%. The biggest loss this year has been the Healthcare sector dropping -0.69%.
Healthcare saw the biggest turnaround from its 5-day performance of -4.33%, as it went up 1.59%. Consumer Staples saw a turn around from its 5-day performance of 0.92% trading down -0.12%.
- Healthcare went up with a 1.59% change.
- Consumer Discretionary went up with a 1.22% change.
- Information Technology went up with a 1.13% change.
- Real Estate went up with a 1.12% change.
- Industrials went up with a 0.89% change.
- Communication Services went up with a 0.85% change.
- Financials went up with a 0.58% change.
- Materials went up with a 0.44% change.
- Utilities went up with a 0.37% change.
- Energy went up with a 0.04% change.
- Consumer Staples went down with a -0.12% change.
Synopsys, Inc. Info
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits (ICs). It offers Fusion Design Platform, a digital design implementation solution; Verification Continuum Platform, which provides virtual prototyping, static and formal verification, simulation, emulation, field-programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions. The company also offers intellectual property (IP) solutions for USB, PCI Express, DDR, Ethernet, SATA, MIPI, HDMI, and Bluetooth low energy applications; analog IP, including data converters and audio codecs; and system-on-chip infrastructure IP, datapath and building block IP, and verification IP products, as well as mathematical and floating point components, and ARM AMBA interconnect fabric and peripherals. In addition, it provides logic libraries and embedded memories; configurable processor cores and application-specific instruction-set processor tools for embedded applications; IP subsystems for audio, sensor, and data fusion functionality; and security IP solutions. Further, the company offers Platform Architect tools for SoC architecture analysis and optimization; virtual prototyping solutions; and HAPS FPGA-based prototyping systems, as well as a series of tools used in the design of optical systems and photonic devices. Additionally, it provides testing tools, services, and programs, which include security testing, managed services, programs and professional services, and training that enable its customers to detect and remediate defects in the software development lifecycle; manufacturing solutions for semiconductor manufacturers to develop fabrication processes; and professional and other services. Synopsys, Inc. has collaboration with Palma Ceia SemiDesign, Inc. to provide ready-to-use NB-IoT solution. The company was founded in 1986 and is headquartered in Mountain View, California.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.